Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigation of Caspofungin Plasma Concentration and Pharmacokinetics in Surgical ICU Patients
2006-001146-13Phase 4Terminated
- Sponsor
- Heidelberg University Hospital
- Start
- Mar 2006
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of caspofungin in mycoses, sponsored by Heidelberg University Hospital. Primary endpoints: Trough concentration (Ctrough) and Peak concentration (Cpeak). Started Mar 2006; status: terminated.
02
Drugs
caspofungin
03
Conditions
mycoses
Beyond the preview
Go deeper on 2006-001146-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001146-13.